Halper Sadeh LLC Encourages Luminar Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights Share Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Luminar Technologies, Inc. (NASDAQ: LAZR) breached their fiduciary duties to shareholders. If you currently own Luminar stock and are a long-term shareholder, ...

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA) breached their fiduciary duties to shareholders. Oct 24, 2025 11:00 AM Eastern Daylight Time Halper Sadeh LLC Encourages Verrica Pharmaceuticals, Inc. Shareholders to Contact the Firm to Discuss Their Rights Share If you currently o ...

Oct 24, 2025 10:40 AM Eastern Daylight Time Halper Sadeh LLC Encourages Dentsply Sirona Inc. Shareholders to Contact the Firm to Discuss Their Rights Share Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Dentsply Sirona Inc. (NASDAQ: XRAY) breached their fiduciary duties to shareholders. If you currently own Dentsply stock ...

Heartland Advisors, an investment management company, released its “Heartland Value Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Small-cap companies started to rebound in the quarter, with the Heartland Value Fund gaining 10.04% compared to a 12.60% return for the Russell 2000® Value Index. In addition, you can check the fund’s top 5 holdings to determine its best picks for 2025. In its third-quarter 2025 investor letter, Heartland Value Fund highlighted stocks suc ...

CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, November 6, 2025, at 8:30 am ET to review its financial results for the third quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s website ...

Core Viewpoint - Dentsply Sirona has appointed Aldo M. Denti as Executive Vice President and Chief Commercial Officer to enhance customer focus and streamline operations within the company [1][3]. Group 1: Appointment Details - Aldo M. Denti will assume the role of Executive Vice President and Chief Commercial Officer effective October 6, 2025 [1]. - The appointment aims to align Global Business Units and Commercial Organizations to improve operational efficiency and customer experience [1][3]. Group 2: Aldo M. Denti's Background - Mr. Denti has over 25 years of experience in the Medical Device and Consumer Health sectors, with a strong track record in sales, marketing, and strategic planning [2][4]. - He previously served as Company Group Chairman, Global Orthopedics, at Johnson & Johnson Medtech, contributing to transformative growth [2][4]. Group 3: Company Strategy and Goals - The new CCO role is expected to strengthen collaboration across business units, unlock synergies, and support global revenue growth [3]. - Dentsply Sirona aims to leverage its diverse product portfolio to enhance customer satisfaction and drive superior growth and profitability [3]. Group 4: Company Overview - Dentsply Sirona is the largest diversified manufacturer of professional dental products and technologies, with a history of over a century in the dental industry [5]. - The company develops and markets a comprehensive range of dental and oral health products, focusing on high-quality and effective solutions for patient care [5].

Core Insights - Investors are increasingly turning to dividend-yielding stocks during market turbulence, as these companies typically have high free cash flows and offer substantial dividend payouts [1] Company Summaries GSK plc (NYSE:GSK) - Dividend Yield: 4.13% - Jefferies analyst Peter Welford downgraded the stock from Buy to Hold on Nov. 12, 2024, with an accuracy rate of 57% [7] - Guggenheim analyst Seamus Fernandez downgraded the stock from Buy to Neutral on Oct. 31, 2024, with an accuracy rate of 73% [7] - Recent News: Luke Miels appointed as CEO Designate, effective Jan. 1, 2026 [7] DENTSPLY SIRONA Inc (NASDAQ:XRAY) - Dividend Yield: 5.04% - UBS analyst Kevin Caliendo maintained a Buy rating but reduced the price target from $25 to $24 on Aug. 8, 2025, with an accuracy rate of 67% [7] - Stifel analyst Jonathan Block maintained a Hold rating and cut the price target from $19 to $17 on Aug. 8, 2025, with an accuracy rate of 71% [7] - Recent News: Decision to retain Wellspect Healthcare after a strategic review on Sept. 8 [7] Bristol-Myers Squibb Company (NYSE:BMY) - Dividend Yield: 5.62% - Citigroup analyst Andrew Baum maintained a Neutral rating and lowered the price target from $51 to $47 on Aug. 1, 2025, with an accuracy rate of 69% [7] - Morgan Stanley analyst Terence Flynn maintained an Underweight rating and reduced the price target from $36 to $34 on July 10, 2025, with an accuracy rate of 63% [7] - Recent News: Announced results from the Phase 3 EXCALIBER-RRMM study on Sept. 23, evaluating iberdomide in combination with standard therapies for multiple myeloma [7]

Core Insights - Dentsply Sirona has integrated Pearl's Second Opinion dental AI capabilities into its cloud-based DS Core imaging software [1] Company Developments - The addition of Pearl's AI technology aims to enhance the diagnostic capabilities of Dentsply Sirona's imaging solutions [1] - This integration reflects a growing trend in the dental industry towards the adoption of artificial intelligence to improve patient outcomes and operational efficiency [1] Industry Trends - The dental industry is increasingly leveraging AI technologies to streamline processes and enhance diagnostic accuracy [1] - The collaboration between Dentsply Sirona and Pearl signifies a shift towards more technologically advanced solutions in dental care [1]

With significant upside potential, DENTSPLY SIRONA Inc. (NASDAQ:XRAY) secures a spot on our list of the 15 Best Robotics Stocks to Buy Under $20. DENTSPLY SIRONA Inc. (XRAY) Presents Refined Strategy Roadmap At the Morgan Stanley 23rd Annual Global Healthcare Conference At the Morgan Stanley 23rd Annual Global Healthcare Conference on September 8, 2025, CEO Dan Scavilla and CFO Matt Garza presented a refined strategy roadmap for DENTSPLY SIRONA Inc. (NASDAQ:XRAY). In order to speed up decision-making, s ...

Company Overview - DENTSPLY SIRONA Inc. (NASDAQ:XRAY) is the world's largest manufacturer of professional dental products and technologies, operating in various segments including imaging, CAD/CAM, endodontics, restoratives, and healthcare consumables through its Wellspect unit [2][3]. Strategic Decisions - The company recently completed a strategic review of Wellspect Healthcare and opted to retain the unit, citing strong growth prospects and innovative products like LoFric catheters, as well as significant untapped market potential in global continence care [3][4]. - CEO Dan Scavilla emphasized that recent investments in Wellspect are leading to solid organic sales growth, and the unit's recurring cash flows will support further innovation across the dental and healthcare sectors [3]. Market Position and Growth Potential - DENTSPLY SIRONA has garnered attention as a cheap healthcare stock due to its combination of recurring revenue and innovation, which provides both stability and growth potential [4]. - The company showcased its latest developments at major healthcare conferences in September 2025, including the Morgan Stanley Global Healthcare Conference and the Baird Global Healthcare Conference, highlighting its commitment to integrated dental technologies [4].